CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
Say something
Tags: Aurobindo Pharma, Aurobindo Pharma Ltd, biotechnology, business, Business/Finance, Citi Venture Group, Clinical Research, contract manufacturing, contract services, health, Health/Medical/Pharmaceuticals, ICICI Venture, India, news, Nicholas Piramal, Orchid Chemicals & Pharmaceuticals, Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals in India, Pharmaceuticals policy, Ranbaxy Laboratories, Sanjiv Kaul, Sequoia Capital, Sequoia Capital Vertriebsgesellschaft mbH, Sun Pharmaceutical, Sun Pharmaceuticals Industries Ltd, USD
ICICI Venture plans to float healthcare holding firm
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
ICICI Venture, keen on part of healthcare pie invests USD 10 million in hospital chain
Private equity firm ICICI Venture has invested USD 10 million to pick a minority stake in urology hospital chain RG Stone Urological Research Institute.
-
-
Flipkart Health+ App Launched
06-04-2022
